Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on January 16, 2003

Stroke. 2003
Published online before print January 16, 2003, doi: 10.1161/01.STR.0000051507.64423.00
A more recent version of this article appeared on February 1, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/2/558    most recent
01.STR.0000051507.64423.00v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chang, C.-F.
Right arrow Articles by Wang, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chang, C.-F.
Right arrow Articles by Wang, Y.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Stroke
*Transient Ischemic Attack
Related Collections
Right arrow Gene expression
Right arrow Growth factors/cytokines
Right arrow Ischemic biology - basic studies
Right arrow Behavioral Changes and Stroke
Right arrow Transient Ischemic Attacks

Submitted on August 26, 2002
Accepted on August 26, 2002

Intravenous Administration of Bone Morphogenetic Protein-7 After Ischemia Improves Motor Function in Stroke Rats

Chen-Fu Chang MD; Shinn-Zong Lin MD, PhD; Yung-Hsiao Chiang MD, PhD; Marisela Morales PhD; Jenny Chou BS; Pamela Lein PhD; Hui-Ling Chen MS; Barry J. Hoffer MD, PhD; and Yun Wang MD, PhD*

From the National Institute on Drug Abuse, National Institutes of Health, Baltimore, Md (C-F.C., M.M., J.C., H-L.C., B.J.H., Y.W.); Tri-Service General Hospital (C-F.C., S-Z.L., Y-H.C.) and Graduate Institute of Life Sciences (H-L.C.), National Defense Medical Center, Taiwan, Republic of China; and Department of Environmental Health Sciences, Johns Hopkins University, Baltimore, Md (P.L.).

* To whom correspondence should be addressed. E-mail: ywang{at}intra.nida.nih.gov.

Background and Purpose--We and others have previously reported that bone morphogenetic protein-7 (BMP-7), given before middle cerebral artery occlusion (MCAO), reduces ischemic injury in brain. Recent studies have indicated that receptors for BMP are upregulated after brain ischemia. It is possible that this upregulation may facilitate endogenous neurorepair in the ischemic brain. The purpose of this study was to determine the neuroregenerative effects of BMP-7 given parenterally after ischemia/reperfusion injury.

Methods--Adult Sprague-Dawley rats were anesthetized with chloral hydrate. The middle cerebral artery was transiently occluded by a filament inserted through the right internal carotid artery. The filament was removed after 60-minute ischemia to allow reperfusion. Some animals were killed 24 hours after MCAO to examine BMP-7 mRNA expression. Other animals received a single dose of intravenous BMP-7 or vehicle at 24 hours after MCAO and were used for subsequent behavioral studies and BMP-7 immunostaining.

Results--BMP-7 mRNA was upregulated 24 hours after MCAO in untreated animals. BMP-7 immunoreactivity was dose-dependently increased on the ischemic side of the hippocampus/dentate on day 6 after MCAO in animals receiving intravenous injection of BMP-7. Animals receiving BMP-7 also showed a decrease in body asymmetry from day 7 to day 14 and an increase in locomotor activity on day 14 after MCAO.

Conclusions--Our data indicate that BMP-7, given parenterally after stroke, can pass through the blood-brain barrier on the ischemic side and induce behavioral recovery in stroke animals at longer testing times.


Key words: bone morphogenetic proteins • growth factors • nerve regeneration • stroke




This article has been cited by other articles:


Home page
NeuroscientistHome page
M. LLorens-Martin, I. Torres-Aleman, and J. L. Trejo
Reviews: Mechanisms Mediating Brain Plasticity: IGF1 and Adult Hippocampal Neurogenesis
Neuroscientist, April 1, 2009; 15(2): 134 - 148.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
W.-C. Shyu, S.-Z. Lin, P.-S. Yen, C.-Y. Su, D.-C. Chen, H.-J. Wang, and H. Li
Stromal Cell-Derived Factor-1{alpha} Promotes Neuroprotection, Angiogenesis, and Mobilization/Homing of Bone Marrow-Derived Cells in Stroke Rats
J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 834 - 849.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
W.-C. Shyu, C.-P. Chen, S.-Z. Lin, Y.-J. Lee, and H. Li
Efficient Tracking of Non-Iron-Labeled Mesenchymal Stem Cells With Serial MRI in Chronic Stroke Rats
Stroke, February 1, 2007; 38(2): 367 - 374.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
W.-C. Shyu, S.-Z. Lin, M.-F. Chiang, C.-Y. Su, and H. Li
Intracerebral peripheral blood stem cell (CD34+) implantation induces neuroplasticity by enhancing beta1 integrin-mediated angiogenesis in chronic stroke rats.
J. Neurosci., March 29, 2006; 26(13): 3444 - 3453.
[Abstract] [Full Text] [PDF]